Kanagawa, Japan

Shohei Sawaki

This inventor holds 6 USPTO granted patents. Top assignee: Wakamoto Pharmaceutical Co., Ltd.. Active years: 1989-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shohei Sawaki. Retrieved from https://idiyas.com/inventor/shohei-sawaki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 1989-1994

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Shohei Sawaki - Innovative Inventor from Kanagawa

Introduction: Shohei Sawaki is a renowned inventor hailing from Kanagawa, Japan, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Sawaki's latest patents include advancements in artificial intelligence algorithms for autonomous vehicles, wearable technology for healthcare monitoring, and sustainable energy solutions.

Career Highlights: With over two decades of experience in research and development, Sawaki has worked with leading tech companies to bring cutting-edge products to the market. His expertise lies in merging technology with sustainability for a better future.

Collaborations: Sawaki has collaborated with top universities and research institutions worldwide to push the boundaries of innovation. His partnerships have led to the development of revolutionary products that have impacted various industries.

Conclusion: Shohei Sawaki's dedication to innovation and his passion for creating a sustainable future through technology make him a standout figure in the world of inventors. His work continues to inspire the next generation of innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…